Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MATVAC: Maternal and Infant BCG and Measles Vaccination Study
NCT04899765Phase 4Recruiting
- Sponsor
- Bandim Health Project
- Start
- May 2021
- Primary completion
- Dec 2025
- Modality
- Live Attenuated Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine, measles virus vaccine live in measles, Tuberculosis (TB), infectious disease, sponsored by Bandim Health Project. Started May 2021; status: recruiting.
02
Drugs
bcg vaccinemeasles virus vaccine live
03
Conditions
measlesTuberculosis (TB)infectious disease
Beyond the preview
Go deeper on NCT04899765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04899765.